{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:27:03Z","timestamp":1786505223327,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prp.2026.156592","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:45Z","timestamp":1781827245000},"page":"156592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["BCG vaccination as an adjunctive strategy in type 1 diabetes: A systematic review of immunometabolic effects and clinical evidence"],"prefix":"10.1016","volume":"286","author":[{"given":"Hedieh Sadat","family":"Shamsnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Peyrovinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Niknejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria","family":"Nikdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porsa","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reihaneh","family":"Mirhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-9097","authenticated-orcid":false,"given":"Amir Hossein","family":"Abdolghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156592_bib1","unstructured":"FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes. 2023; Available from: \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-class-medicines-treat-pediatric-type-2-diabetes\u3009."},{"key":"10.1016\/j.prp.2026.156592_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0685-4","article-title":"The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality","volume":"14","author":"Harris","year":"2016","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"50","key":"10.1016\/j.prp.2026.156592_bib4","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1016\/j.vaccine.2021.11.038","article-title":"100 years of the Bacillus Calmette-Gu\u00e9rin vaccine","volume":"39","author":"Bettencourt","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.prp.2026.156592_bib5","first-page":"531","article-title":"The BCG experience: implications for future vaccines against tuberculosis","author":"Bloom","year":"1994","journal-title":"Tuberc. Pathog. Prot. Control."},{"issue":"47","key":"10.1016\/j.prp.2026.156592_bib6","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","article-title":"Recombinant mycobacterium bovis BCG","volume":"27","author":"Bastos","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.prp.2026.156592_bib7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/vaccines10071157","article-title":"Past, present and future of Bacillus Calmette-Gu\u00e9rin vaccine use in China","volume":"10","author":"Li","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1152\/physrev.00031.2021","article-title":"Trained immunity: adaptation within innate immune mechanisms","volume":"103","author":"Dom\u00ednguez-Andr\u00e9s","year":"2023","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.prp.2026.156592_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41585-020-0346-4","article-title":"Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer","volume":"17","author":"van Puffelen","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/eji.200838620","article-title":"Safety and efficacy of neonatal vaccination","volume":"39","author":"Demirjian","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"8986","key":"10.1016\/j.prp.2026.156592_bib11","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.prp.2026.156592_bib12","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.immuni.2024.07.021","article-title":"BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses","volume":"57","author":"Sun","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-093019-123619","article-title":"Epigenetic remodeling in innate immunity and inflammation","volume":"39","author":"Zhang","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.prp.2026.156592_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.copbio.2019.12.008","article-title":"Metabolic regulation of epigenetic remodeling in immune cells","volume":"63","author":"Britt","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"issue":"6","key":"10.1016\/j.prp.2026.156592_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.amjms.2021.03.003","article-title":"Bacillus Calmette-Guerin vaccine and nonspecific immunity","volume":"361","author":"Parmar","year":"2021","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3934\/microbiol.2021007","article-title":"Bacillus Calmette-Guerin (BCG): the adroit vaccine","volume":"7","author":"Adesanya","year":"2021","journal-title":"AIMS Microbiol."},{"issue":"4","key":"10.1016\/j.prp.2026.156592_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-3083.2005.01674.x","article-title":"DNA vaccination using Bacillus Calmette-Guerin-DNA as an adjuvant to enhance immune response to three kinds of swine diseases","volume":"62","author":"Zhang","year":"2005","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"10.1016\/j.prp.2026.156592_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/vaccines10030390","article-title":"Protective efficacy of BCG vaccine against Mycobacterium leprae and non-tuberculous mycobacterial infections","volume":"10","author":"Orujyan","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.prp.2026.156592_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1158\/1078-0432.CCR-16-1189","article-title":"intravesical bacillus Calmette Guerin combined with a cancer vaccine increases local t-cell responses in non-muscle\u2013invasive bladder cancer patients","volume":"23","author":"Derr\u00e9","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2026.156592_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ITT.S202006","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update","author":"Guallar-Garrido","year":"2020","journal-title":"ImmunoTargets Ther."},{"issue":"11","key":"10.1016\/j.prp.2026.156592_bib21","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1586\/era.11.163","article-title":"Role of bacillus Calmette\u2013Gu\u00e9rin in the treatment of advanced melanoma","volume":"11","author":"Stewart","year":"2011","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.prp.2026.156592_bib22","doi-asserted-by":"crossref","unstructured":"Faustman, D.L., et al., Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes. 2012.","DOI":"10.1371\/journal.pone.0041756"},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib23","first-page":"93","article-title":"Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety","volume":"68","author":"Milstien","year":"1990","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"10.1016\/j.prp.2026.156592_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2014different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.prp.2026.156592_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/338462","article-title":"National study of adverse reactions after vaccination with bacille Calmette-Gu\u00e9rin","volume":"34","author":"Turnbull","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.prp.2026.156592_bib26","author":"Nicol","year":"2002","journal-title":"Intradermal BCG vaccination-adverse reactions and their management"},{"key":"10.1016\/j.prp.2026.156592_bib27","first-page":"108","article-title":"BCG complications: estimate of the risk among vaccinated subjects and statistical analysis of thein main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv. Tuberc. Res."},{"key":"10.1016\/j.prp.2026.156592_bib28","doi-asserted-by":"crossref","first-page":"s45","DOI":"10.2223\/JPED.1499","article-title":"BCG vaccine: efficacy and indications for vaccination and revaccination","volume":"82","author":"Barreto","year":"2006","journal-title":"J. De. Pediatr."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbspin.2004.12.003","article-title":"Osteoarticular side effects of BCG therapy","volume":"73","author":"Clavel","year":"2006","journal-title":"Jt. Bone Spine"},{"issue":"8","key":"10.1016\/j.prp.2026.156592_bib30","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1080\/21645515.2019.1706930","article-title":"BCG: a vaccine with multiple faces","volume":"16","author":"Yamazaki-Nakashimada","year":"2020","journal-title":"Human. Vaccin. Immunother."},{"issue":"4","key":"10.1016\/j.prp.2026.156592_bib31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies","volume":"133","author":"Marciano","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.prp.2026.156592_bib32","article-title":"Bacille Calmette-Gu\u00e9rin (BCG) osteomyelitis: a rare complication of BCG vaccination","volume":"17","author":"Venugopal","year":"2024","journal-title":"BMJ Case Rep. CP"},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib33","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1038\/s41598-020-61152-6","article-title":"Long-term follow-up of osteomyelitis caused by Bacille Calmette-Gu\u00e9rin vaccination in immunocompetent children","volume":"10","author":"Tsai","year":"2020","journal-title":"Sci. Rep."},{"issue":"31","key":"10.1016\/j.prp.2026.156592_bib34","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1016\/j.vaccine.2007.04.057","article-title":"Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Kohl","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.prp.2026.156592_bib35","first-page":"761","article-title":"Complications after BCG vaccination in children from Urban area of Lodz in 1994-1995","volume":"65","author":"Pankowska","year":"1997","journal-title":"Pneumologia I Alergologia Polska"},{"issue":"5","key":"10.1016\/j.prp.2026.156592_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3201\/eid1305.060865","article-title":"Disseminated bacillus Calmette-Gu\u00e9rin infection and immunodeficiency","volume":"13","author":"Bernatowska","year":"2007","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.prp.2026.156592_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.2004","article-title":"Diabetes mellitus, the fastest growing global public health concern: early detection should be focused","volume":"7","author":"Hossain","year":"2024","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.prp.2026.156592_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.prp.2026.156592_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.47672\/ejb.409","article-title":"A modern overview on diabetes mellitus: a chronic endocrine disorder","volume":"5","author":"Mukhtar","year":"2020","journal-title":"Eur. J. Biol."},{"issue":"04","key":"10.1016\/j.prp.2026.156592_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/ajm.ajm_53_20","article-title":"Pathophysiology of diabetes: an overview","volume":"10","author":"Banday","year":"2020","journal-title":"Avicenna J. Med."},{"issue":"4","key":"10.1016\/j.prp.2026.156592_bib41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12013-023-01164-x","article-title":"Sodium glucose transporter-2 inhibitors (SGLT2Is)-TLRs axis modulates diabetes","volume":"81","author":"Niknejad","year":"2023","journal-title":"Cell. Biochem. Biophys."},{"key":"10.1016\/j.prp.2026.156592_bib42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12020-015-0534-9","article-title":"Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes","volume":"49","author":"Poudel","year":"2015","journal-title":"Endocrine"},{"issue":"7121","key":"10.1016\/j.prp.2026.156592_bib43","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.prp.2026.156592_bib44","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mpmed.2018.10.002","article-title":"What is diabetes?","volume":"47","author":"Egan","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2026.156592_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112724","article-title":"Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence","volume":"140","author":"Huang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"9911","key":"10.1016\/j.prp.2026.156592_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"lancet"},{"issue":"4","key":"10.1016\/j.prp.2026.156592_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.trsl.2012.01.009","article-title":"Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers","volume":"159","author":"Lyons","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.prp.2026.156592_bib49","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2147\/DMSO.S248844","article-title":"Effects of glycated hemoglobin level on bone metabolism biomarkers in patients with type 2 diabetes mellitus","author":"Zhao","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"10","key":"10.1016\/j.prp.2026.156592_bib50","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41591-020-1010-5","article-title":"A digital biomarker of diabetes from smartphone-based vascular signals","volume":"26","author":"Avram","year":"2020","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.prp.2026.156592_bib51","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.sjbs.2018.05.027","article-title":"Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals","volume":"25","author":"Khan","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156592_bib52","first-page":"1939","article-title":"Biomarkers for cardiovascular risk in patients with diabetes","author":"Berezin","year":"2016","journal-title":"BMJ Publ. Group. Ltd Br. Cardiovasc. Soc."},{"issue":"9","key":"10.1016\/j.prp.2026.156592_bib53","article-title":"Late stage complications of diabetes and insulin resistance","volume":"2","author":"Soumya","year":"2011","journal-title":"J. Diabetes Metab."},{"key":"10.1016\/j.prp.2026.156592_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10792-014-0018-6","article-title":"Link between retinopathy and nephropathy caused by complications of diabetes mellitus type 2","volume":"35","author":"Kotlarsky","year":"2015","journal-title":"Int. Ophthalmol."},{"issue":"6","key":"10.1016\/j.prp.2026.156592_bib55","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2337\/diacare.27.6.1506","article-title":"Diabetes complications","volume":"27","author":"Bloomgarden","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.prp.2026.156592_bib56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13300-019-00743-7","article-title":"Insulin therapy in adults with type 1 diabetes mellitus: a narrative review","volume":"11","author":"Jane\u017e","year":"2020","journal-title":"Diabetes Ther."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","article-title":"New frontiers in the treatment of type 1 diabetes","volume":"31","author":"Warshauer","year":"2020","journal-title":"Cell. Metab."},{"issue":"8","key":"10.1016\/j.prp.2026.156592_bib58","doi-asserted-by":"crossref","first-page":"375","DOI":"10.31083\/ph.2020.0494","article-title":"Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Gu\u00e9rin vaccine: a case study of beta cells regeneration","volume":"75","author":"Ayoub","year":"2020","journal-title":"Pharmazie"},{"issue":"11","key":"10.1016\/j.prp.2026.156592_bib59","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1007\/s13300-021-01163-2","article-title":"The role of pediatric BCG vaccine in type 1 diabetes onset","volume":"12","author":"Doupis","year":"2021","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.prp.2026.156592_bib60","series-title":"The Value of BCG and TNF in Autoimmunity","first-page":"81","article-title":"Chapter 6 - TNF, BCG, and the proteasome in autoimmunity: an overview of the pathways & results of a phase I study in type 1 diabetes","author":"Faustman","year":"2014"},{"issue":"8","key":"10.1016\/j.prp.2026.156592_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib62","article-title":"MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects","volume":"3","author":"Faustman","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.prp.2026.156592_bib63","unstructured":"Fleishman, G., Tuberculosis Vaccine Could Reverse Type 1 Diabetes, Study Shows."},{"issue":"41","key":"10.1016\/j.prp.2026.156592_bib64","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1016\/j.vaccine.2020.07.066","article-title":"Newborn BCG vaccination complemented by boosting correlates better with reduced juvenile diabetes in females, than vaccination alone","volume":"38","author":"Klein","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"K\u00fchtreiber","year":"2018","journal-title":"npj Vaccin."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib66","first-page":"1","article-title":"BCG vaccine-an innovation for diabetes treatment in Pakistan?","volume":"29","author":"Lilani","year":"2017","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"issue":"10","key":"10.1016\/j.prp.2026.156592_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103150","article-title":"Bacillus calmette-guerin's beneficial impact on glucose metabolism: Evidence for broad based applications","volume":"24","author":"Shpilsky","year":"2021","journal-title":"Iscience"},{"key":"10.1016\/j.prp.2026.156592_bib68","doi-asserted-by":"crossref","DOI":"10.15605\/jafes.037.S2.68","article-title":"Use of bacillus calmette\u2013guerin vaccination to preserve beta cell function in type 1 diabetes mellitus","volume":"37","author":"Wei","year":"2022","journal-title":"J. ASEAN Fed. Endocr. Soc."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276423","article-title":"Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies","volume":"18","author":"Dias","year":"2023","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.prp.2026.156592_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001765","article-title":"Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination","volume":"20","author":"Koeken","year":"2022","journal-title":"PLoS. Biol."},{"issue":"7","key":"10.1016\/j.prp.2026.156592_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14070683","article-title":"NOD2 (Nucleotide-Binding Oligomerization Domain-Containing Protein 2)-mediated modulation of the immune response induced by BCG (Bacillus Calmette-Gu\u00e9rin) Bacilli","volume":"14","author":"Jurczak","year":"2025","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.prp.2026.156592_bib72","article-title":"BCG vaccination suppresses glucose intolerance progression in high-fat-diet-fed C57BL\/6 Mice","volume":"60","author":"Arakawa","year":"2024","journal-title":"Med. (Kaunas. )"},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-020-0169-6","article-title":"BCG and BCG\u0394BCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines","volume":"5","author":"Segura-Cerda","year":"2020","journal-title":"NPJ Vaccin."},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.399","article-title":"Inhibition of the MAP3 kinase Tpl2 protects rodent and human \u03b2-cells from apoptosis and dysfunction induced by cytokines and enhances anti-inflammatory actions of exendin-4","volume":"7","author":"Varin","year":"2016","journal-title":"Cell. Death Dis."},{"issue":"10","key":"10.1016\/j.prp.2026.156592_bib75","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2337\/diacare.22.10.1703","article-title":"Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study","volume":"22","author":"Allen","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.prp.2026.156592_bib76","article-title":"The non-significant benefit of BCG vaccination for the treatment of Iranian patients with type 1 diabetes up to 48 weeks: a controversial result","volume":"35","author":"Moghtaderi","year":"2021","journal-title":"Med. J. Islam. Repub. Iran."},{"issue":"5","key":"10.1016\/j.prp.2026.156592_bib77","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/diacare.28.5.1204","article-title":"Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes","volume":"28","author":"Huppmann","year":"2005","journal-title":"Diabetes care"},{"key":"10.1016\/j.prp.2026.156592_bib78","series-title":"The Value of BCG and TNF in Autoimmunity","first-page":"52","article-title":"The protective effect of the BCG vaccine on the development of type 1 diabetes in humans","author":"Karaci","year":"2014"},{"issue":"2","key":"10.1016\/j.prp.2026.156592_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/ppe.12263","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccination in infancy and risk of childhood diabetes","volume":"30","author":"Rousseau","year":"2016","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"3","key":"10.1016\/j.prp.2026.156592_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101337","article-title":"Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood","volume":"48","author":"Corsenac","year":"2022","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.prp.2026.156592_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106893","article-title":"Association between Bacillus Calmette-Guerin vaccination and type 1 diabetes in adolescence: a population-based birth cohort study in Quebec, Canada","volume":"154","author":"Corsenac","year":"2022","journal-title":"Prev. Med."},{"issue":"4","key":"10.1016\/j.prp.2026.156592_bib82","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/pathogens12040581","article-title":"BCG vaccination and the risk of type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Jamshidi","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.prp.2026.156592_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2024.103102","article-title":"Significance of Bacillus Calmette-Guerin (BCG) vaccine intervention for patients with Type 1 Diabetes (T1D): A systematic review and meta-analysis","author":"Korde","year":"2024","journal-title":"Diabetes & Metabolic Syndrome Clinical Research & Reviews"},{"issue":"6","key":"10.1016\/j.prp.2026.156592_bib84","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/joim.13050","article-title":"Benefits of BCG-induced metabolic switch from oxidative phosphorylation to aerobic glycolysis in autoimmune and nervous system diseases","volume":"288","author":"Faustman","year":"2020","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156592_bib85","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tem.2018.11.006","article-title":"BCG therapy for type 1 diabetes: restoration of balanced immunity and metabolism","volume":"30","author":"K\u00fchtreiber","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.prp.2026.156592_bib86","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2337\/diacare.21.10.1691","article-title":"Effect of bacille Calmette-Guerin vaccination on C-peptide secretion in children newly diagnosed with IDDM","volume":"21","author":"Elliott","year":"1998","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.prp.2026.156592_bib87","article-title":"Therapeutic effects of BCG vaccination on type 1 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"2020","author":"Chang","year":"2020","journal-title":"J. Diabetes Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:31:03Z","timestamp":1786501863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826002451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":87,"alternative-id":["S0344033826002451"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156592","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG vaccination as an adjunctive strategy in type 1 diabetes: A systematic review of immunometabolic effects and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156592"}}